Beriplex P/N 500 820 Unit (Protein C POWDER FOR SOLUTION) 820 UNIT

BERIPLEX P/N 500 820 UNIT is a protein C powder for solution, used for intravenous administration. This medication is designed to support blood clotting and is manufactured by CSL Behring Canada Inc.

Strength

820 UNIT

Pack Size

30ML

Manufacturer / TM Owner

CSL BEHRING CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BERIPLEX P/N 500 820 UNIT is primarily used to manage conditions related to blood clotting. Protein C is a natural anticoagulant that helps regulate blood clotting processes. This medication may be prescribed for individuals with deficiencies in protein C, which can lead to excessive clotting. What is BERIPLEX P/N 500 820 UNIT used for? It is often used in situations where there is a need to prevent or treat abnormal blood clotting.

Side Effects

Common effects of BERIPLEX P/N 500 820 UNIT may include reactions at the injection site, such as redness or swelling. Some individuals might experience mild allergic reactions. It is important to monitor for any signs of adverse effects and consult a healthcare provider if they occur.

Precautions & Warnings

BERIPLEX P/N 500 820 UNIT should be handled with care, ensuring proper storage and preparation. It is crucial to follow the instructions for intravenous administration to avoid complications. Individuals with known allergies to protein C or any of the ingredients should avoid using this medication.

Avoid Interactions

BERIPLEX P/N 500 820 UNIT may interact with other medications that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods might also influence the effectiveness of this medication.

Frequently Asked Questions

BERIPLEX P/N 500 820 UNIT is used to manage conditions related to blood clotting, particularly in individuals with protein C deficiencies.

BERIPLEX P/N 500 820 UNIT is administered intravenously after being reconstituted from its powder form.

Common side effects may include reactions at the injection site, such as redness or swelling, and mild allergic reactions.

It is important to consult a healthcare provider before using BERIPLEX P/N 500 820 UNIT with other medications, as interactions may occur.

Individuals with known allergies to protein C or any of the ingredients in BERIPLEX P/N 500 820 UNIT should avoid using this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.